Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report
Abstract The advent of immune checkpoint inhibitors (ICIs) has transformed cancer therapy, but their association with immune-related adverse events presents a new and complex challenge for clinicians. In this report, we present the case of a 60-year-old Han Chinese woman who developed myasthenia gra...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04288-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|